Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1987-09-14
1990-02-06
Konopka, Paul E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
2603972, 556436, 560119, 568374, 568819, A61K 3159, C07J 900
Patent
active
048988553
ABSTRACT:
The invention is directed to deuterated vitamin D analogs, and processes and intermediates for their preparation. The end products, that is the deuterated vitamin D analogs, are useful for the treatment osteoporosis and cutaneous inflammations such as psoriasis, and contact dermatitis.
REFERENCES:
patent: 4225596 (1980-09-01), DeLuca
patent: 4269777 (1981-05-01), DeLuca et al.
patent: 4297289 (1981-10-01), DeLuca et al.
patent: 4424161 (1984-01-01), Holick
patent: 4508651 (1985-04-01), Baggiolini et al.
patent: 4804502 (1989-02-01), Baggiolini et al.
Chemical Abstracts, vol. 90, no. 3, Jan. 15, 1979, 17948 W.
American Chemical Society, vol. 18, No. 18, 1979, pp. 3977-3983, Esvelt et al.
FEBS Letters, vol. 94, No. 2, Oct. 1978, pp. 228-230, Redel et al.
American Chemical Society, vol. 18, No. 22, 1979, pp. 4775-4780, Wichmann et al.
Baggiolini Enrico G.
Hennessy Bernard M.
Uskokovic Milan R.
Boxer Matthew
Gould George M.
Hoffman-La Roche Inc.
Konopka Paul E.
Leon Bernard S.
LandOfFree
Deuterated analogs of 1,25-dihydroxycholecalciferol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Deuterated analogs of 1,25-dihydroxycholecalciferol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Deuterated analogs of 1,25-dihydroxycholecalciferol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-441907